Overall, the efficacy of insulinoma-associated protein 1 (INSM1) as an immunohistochemical marker for neuroendocrine neoplasms has been supported by various clinical studies demonstrating its high sensitivity and even higher specificity for detecting NETs of various sites. Here, INSM1 is linked to neuroendocrine neoplasm.